Prevalence of trachoma in the Kayes region of Mali eight years after stopping mass drug administration

In 2009, three years after stopping mass treatment with azithromycin, a trachoma impact survey in four health districts in the Kayes region of Mali found a prevalence of trachomatous inflammation-follicular (TF) among children aged 1 to 9 years of >5% and a trachomatous trichiasis (TT) prevalence...

Full description

Saved in:
Bibliographic Details
Published inPLoS neglected tropical diseases Vol. 12; no. 2; p. e0006289
Main Authors Traoré, Lamine, Dembele, Benoit, Keita, Modibo, Reid, Steven D, Dembéle, Mahamadou, Mariko, Bréhima, Coulibaly, Famolo, Goldman, Whitney, Traoré, Dramane, Coulibaly, Daouda, Guindo, Boubacar, Amon, Joseph J, Knieriemen, Marily, Zhang, Yaobi
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 12.02.2018
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract In 2009, three years after stopping mass treatment with azithromycin, a trachoma impact survey in four health districts in the Kayes region of Mali found a prevalence of trachomatous inflammation-follicular (TF) among children aged 1 to 9 years of >5% and a trachomatous trichiasis (TT) prevalence within the general population (≥1-year-old) of <1%. As a result, the government's national trachoma program expanded trichiasis surgery and related activities required to achieve trachoma elimination. In 2015, to assess progress towards elimination, a follow-up impact survey was conducted in the Kayes, Kéniéba, Nioro and Yélimané health districts. The survey used district level two-stage cluster random sampling methodology with 20 clusters of 30 households in each evaluation unit. Subjects were eligible for examination if they were ≥1 year. TF and TT cases were identified and confirmed by experienced ophthalmologists. In total 14,159 people were enumerated and 11,620 (82%) were examined. TF prevalence (95% confidence interval (CI)) was 0.5% (0.3-1%) in Kayes, 0.8% (0.4-1.7%) in Kéniéba, 0.2% (0-0.9%) in Nioro and 0.3% (0.1-1%) in Yélimané. TT prevalence (95% CI) was 0.04% (0-0.25%) in Kayes, 0.29% (0.11-0.6%) in Kéniéba, 0.04% (0-0.25%) in Nioro and 0.07% (0-0.27%) in Yélimané. Eight years after stopping MDA and intensifying trichiasis surgery outreach campaigns, all four districts reached the TF elimination threshold of <5% and three of four districts reached the TT elimination threshold of <0.1%.
AbstractList Background In 2009, three years after stopping mass treatment with azithromycin, a trachoma impact survey in four health districts in the Kayes region of Mali found a prevalence of trachomatous inflammation-follicular (TF) among children aged 1 to 9 years of >5% and a trachomatous trichiasis (TT) prevalence within the general population ([greater than or equal to]1-year-old) of <1%. As a result, the government's national trachoma program expanded trichiasis surgery and related activities required to achieve trachoma elimination. Methodology/Principal findings In 2015, to assess progress towards elimination, a follow-up impact survey was conducted in the Kayes, Kéniéba, Nioro and Yélimané health districts. The survey used district level two-stage cluster random sampling methodology with 20 clusters of 30 households in each evaluation unit. Subjects were eligible for examination if they were [greater than or equal to]1 year. TF and TT cases were identified and confirmed by experienced ophthalmologists. In total 14,159 people were enumerated and 11,620 (82%) were examined. TF prevalence (95% confidence interval (CI)) was 0.5% (0.3-1%) in Kayes, 0.8% (0.4-1.7%) in Kéniéba, 0.2% (0-0.9%) in Nioro and 0.3% (0.1-1%) in Yélimané. TT prevalence (95% CI) was 0.04% (0-0.25%) in Kayes, 0.29% (0.11-0.6%) in Kéniéba, 0.04% (0-0.25%) in Nioro and 0.07% (0-0.27%) in Yélimané. Conclusions/Significance Eight years after stopping MDA and intensifying trichiasis surgery outreach campaigns, all four districts reached the TF elimination threshold of <5% and three of four districts reached the TT elimination threshold of <0.1%.
In 2009, three years after stopping mass treatment with azithromycin, a trachoma impact survey in four health districts in the Kayes region of Mali found a prevalence of trachomatous inflammation-follicular (TF) among children aged 1 to 9 years of >5% and a trachomatous trichiasis (TT) prevalence within the general population ([greater than or equal to]1-year-old) of <1%. As a result, the government's national trachoma program expanded trichiasis surgery and related activities required to achieve trachoma elimination. In 2015, to assess progress towards elimination, a follow-up impact survey was conducted in the Kayes, Kéniéba, Nioro and Yélimané health districts. The survey used district level two-stage cluster random sampling methodology with 20 clusters of 30 households in each evaluation unit. Subjects were eligible for examination if they were [greater than or equal to]1 year. TF and TT cases were identified and confirmed by experienced ophthalmologists. In total 14,159 people were enumerated and 11,620 (82%) were examined. TF prevalence (95% confidence interval (CI)) was 0.5% (0.3-1%) in Kayes, 0.8% (0.4-1.7%) in Kéniéba, 0.2% (0-0.9%) in Nioro and 0.3% (0.1-1%) in Yélimané. TT prevalence (95% CI) was 0.04% (0-0.25%) in Kayes, 0.29% (0.11-0.6%) in Kéniéba, 0.04% (0-0.25%) in Nioro and 0.07% (0-0.27%) in Yélimané. Eight years after stopping MDA and intensifying trichiasis surgery outreach campaigns, all four districts reached the TF elimination threshold of <5% and three of four districts reached the TT elimination threshold of <0.1%.
Background In 2009, three years after stopping mass treatment with azithromycin, a trachoma impact survey in four health districts in the Kayes region of Mali found a prevalence of trachomatous inflammation-follicular (TF) among children aged 1 to 9 years of >5% and a trachomatous trichiasis (TT) prevalence within the general population (≥1-year-old) of <1%. As a result, the government’s national trachoma program expanded trichiasis surgery and related activities required to achieve trachoma elimination. Methodology/Principal findings In 2015, to assess progress towards elimination, a follow-up impact survey was conducted in the Kayes, Kéniéba, Nioro and Yélimané health districts. The survey used district level two-stage cluster random sampling methodology with 20 clusters of 30 households in each evaluation unit. Subjects were eligible for examination if they were ≥1 year. TF and TT cases were identified and confirmed by experienced ophthalmologists. In total 14,159 people were enumerated and 11,620 (82%) were examined. TF prevalence (95% confidence interval (CI)) was 0.5% (0.3-1%) in Kayes, 0.8% (0.4-1.7%) in Kéniéba, 0.2% (0-0.9%) in Nioro and 0.3% (0.1-1%) in Yélimané. TT prevalence (95% CI) was 0.04% (0-0.25%) in Kayes, 0.29% (0.11-0.6%) in Kéniéba, 0.04% (0-0.25%) in Nioro and 0.07% (0-0.27%) in Yélimané. Conclusions/Significance Eight years after stopping MDA and intensifying trichiasis surgery outreach campaigns, all four districts reached the TF elimination threshold of <5% and three of four districts reached the TT elimination threshold of <0.1%.
Trachoma is a leading infectious cause of preventable blindness worldwide. The World Health Organization (WHO) recommends that endemic states implement the SAFE strategy (surgery for trichiasis, antibiotic treatment, facial cleanliness and environmental improvement) to achieve trachoma elimination by the year 2020. Mali has implemented this strategy from 2002. In the Kayes region in southwest Mali, the districts of Kayes, Kéniéba, Nioro and Yélimané stopped antibiotic treatment in 2006 after three rounds of mass drug administration (MDA). In 2009 an assessment was conducted and found that the prevalence of active trachoma (TF) among children aged 1–9 years and trichiasis (TT) prevalence in adults were above the elimination thresholds in these districts. An intensified effort to expand trichiasis surgery and related interventions, including community-based behavior change communication on facial cleanliness and environmental improvement activities using women’s groups, community health workers, and radio. A follow-up survey was conducted in 2015 in the four districts to assess whether one more round of mass treatment was needed. The results showed that TF prevalence in all four health districts decreased to below the 5% elimination threshold and three of four districts achieved the TT elimination threshold of <0.1%.
Background In 2009, three years after stopping mass treatment with azithromycin, a trachoma impact survey in four health districts in the Kayes region of Mali found a prevalence of trachomatous inflammation-follicular (TF) among children aged 1 to 9 years of >5% and a trachomatous trichiasis (TT) prevalence within the general population (≥1-year-old) of <1%. As a result, the government’s national trachoma program expanded trichiasis surgery and related activities required to achieve trachoma elimination. Methodology/Principal findings In 2015, to assess progress towards elimination, a follow-up impact survey was conducted in the Kayes, Kéniéba, Nioro and Yélimané health districts. The survey used district level two-stage cluster random sampling methodology with 20 clusters of 30 households in each evaluation unit. Subjects were eligible for examination if they were ≥1 year. TF and TT cases were identified and confirmed by experienced ophthalmologists. In total 14,159 people were enumerated and 11,620 (82%) were examined. TF prevalence (95% confidence interval (CI)) was 0.5% (0.3-1%) in Kayes, 0.8% (0.4-1.7%) in Kéniéba, 0.2% (0-0.9%) in Nioro and 0.3% (0.1-1%) in Yélimané. TT prevalence (95% CI) was 0.04% (0-0.25%) in Kayes, 0.29% (0.11-0.6%) in Kéniéba, 0.04% (0-0.25%) in Nioro and 0.07% (0-0.27%) in Yélimané. Conclusions/Significance Eight years after stopping MDA and intensifying trichiasis surgery outreach campaigns, all four districts reached the TF elimination threshold of <5% and three of four districts reached the TT elimination threshold of <0.1%.
In 2009, three years after stopping mass treatment with azithromycin, a trachoma impact survey in four health districts in the Kayes region of Mali found a prevalence of trachomatous inflammation-follicular (TF) among children aged 1 to 9 years of >5% and a trachomatous trichiasis (TT) prevalence within the general population (≥1-year-old) of <1%. As a result, the government's national trachoma program expanded trichiasis surgery and related activities required to achieve trachoma elimination. In 2015, to assess progress towards elimination, a follow-up impact survey was conducted in the Kayes, Kéniéba, Nioro and Yélimané health districts. The survey used district level two-stage cluster random sampling methodology with 20 clusters of 30 households in each evaluation unit. Subjects were eligible for examination if they were ≥1 year. TF and TT cases were identified and confirmed by experienced ophthalmologists. In total 14,159 people were enumerated and 11,620 (82%) were examined. TF prevalence (95% confidence interval (CI)) was 0.5% (0.3-1%) in Kayes, 0.8% (0.4-1.7%) in Kéniéba, 0.2% (0-0.9%) in Nioro and 0.3% (0.1-1%) in Yélimané. TT prevalence (95% CI) was 0.04% (0-0.25%) in Kayes, 0.29% (0.11-0.6%) in Kéniéba, 0.04% (0-0.25%) in Nioro and 0.07% (0-0.27%) in Yélimané. Eight years after stopping MDA and intensifying trichiasis surgery outreach campaigns, all four districts reached the TF elimination threshold of <5% and three of four districts reached the TT elimination threshold of <0.1%.
In 2009, three years after stopping mass treatment with azithromycin, a trachoma impact survey in four health districts in the Kayes region of Mali found a prevalence of trachomatous inflammation-follicular (TF) among children aged 1 to 9 years of >5% and a trachomatous trichiasis (TT) prevalence within the general population (≥1-year-old) of <1%. As a result, the government's national trachoma program expanded trichiasis surgery and related activities required to achieve trachoma elimination.In 2015, to assess progress towards elimination, a follow-up impact survey was conducted in the Kayes, Kéniéba, Nioro and Yélimané health districts. The survey used district level two-stage cluster random sampling methodology with 20 clusters of 30 households in each evaluation unit. Subjects were eligible for examination if they were ≥1 year. TF and TT cases were identified and confirmed by experienced ophthalmologists. In total 14,159 people were enumerated and 11,620 (82%) were examined. TF prevalence (95% confidence interval (CI)) was 0.5% (0.3-1%) in Kayes, 0.8% (0.4-1.7%) in Kéniéba, 0.2% (0-0.9%) in Nioro and 0.3% (0.1-1%) in Yélimané. TT prevalence (95% CI) was 0.04% (0-0.25%) in Kayes, 0.29% (0.11-0.6%) in Kéniéba, 0.04% (0-0.25%) in Nioro and 0.07% (0-0.27%) in Yélimané.Eight years after stopping MDA and intensifying trichiasis surgery outreach campaigns, all four districts reached the TF elimination threshold of <5% and three of four districts reached the TT elimination threshold of <0.1%.
BACKGROUNDIn 2009, three years after stopping mass treatment with azithromycin, a trachoma impact survey in four health districts in the Kayes region of Mali found a prevalence of trachomatous inflammation-follicular (TF) among children aged 1 to 9 years of >5% and a trachomatous trichiasis (TT) prevalence within the general population (≥1-year-old) of <1%. As a result, the government's national trachoma program expanded trichiasis surgery and related activities required to achieve trachoma elimination.METHODOLOGY/PRINCIPAL FINDINGSIn 2015, to assess progress towards elimination, a follow-up impact survey was conducted in the Kayes, Kéniéba, Nioro and Yélimané health districts. The survey used district level two-stage cluster random sampling methodology with 20 clusters of 30 households in each evaluation unit. Subjects were eligible for examination if they were ≥1 year. TF and TT cases were identified and confirmed by experienced ophthalmologists. In total 14,159 people were enumerated and 11,620 (82%) were examined. TF prevalence (95% confidence interval (CI)) was 0.5% (0.3-1%) in Kayes, 0.8% (0.4-1.7%) in Kéniéba, 0.2% (0-0.9%) in Nioro and 0.3% (0.1-1%) in Yélimané. TT prevalence (95% CI) was 0.04% (0-0.25%) in Kayes, 0.29% (0.11-0.6%) in Kéniéba, 0.04% (0-0.25%) in Nioro and 0.07% (0-0.27%) in Yélimané.CONCLUSIONS/SIGNIFICANCEEight years after stopping MDA and intensifying trichiasis surgery outreach campaigns, all four districts reached the TF elimination threshold of <5% and three of four districts reached the TT elimination threshold of <0.1%.
Audience Academic
Author Keita, Modibo
Coulibaly, Famolo
Traoré, Dramane
Amon, Joseph J
Guindo, Boubacar
Dembele, Benoit
Dembéle, Mahamadou
Coulibaly, Daouda
Traoré, Lamine
Goldman, Whitney
Mariko, Bréhima
Knieriemen, Marily
Reid, Steven D
Zhang, Yaobi
AuthorAffiliation University of California San Francisco, UNITED STATES
1 Programme National de la Santé Oculaire, Ministère de la Santé, Bamako, Mali
2 Mali Office, Helen Keller International, Bamako, Mali
5 Regional Office for Africa, Helen Keller International, Dakar, Senegal
3 Headquarters, Helen Keller International, New York, New York, United States of America
4 District Sanitaire de Kita, Direction Régionale de la Santé de Kayes, Kita, Mali
AuthorAffiliation_xml – name: 1 Programme National de la Santé Oculaire, Ministère de la Santé, Bamako, Mali
– name: University of California San Francisco, UNITED STATES
– name: 5 Regional Office for Africa, Helen Keller International, Dakar, Senegal
– name: 4 District Sanitaire de Kita, Direction Régionale de la Santé de Kayes, Kita, Mali
– name: 3 Headquarters, Helen Keller International, New York, New York, United States of America
– name: 2 Mali Office, Helen Keller International, Bamako, Mali
Author_xml – sequence: 1
  givenname: Lamine
  surname: Traoré
  fullname: Traoré, Lamine
  organization: Programme National de la Santé Oculaire, Ministère de la Santé, Bamako, Mali
– sequence: 2
  givenname: Benoit
  surname: Dembele
  fullname: Dembele, Benoit
  organization: Mali Office, Helen Keller International, Bamako, Mali
– sequence: 3
  givenname: Modibo
  surname: Keita
  fullname: Keita, Modibo
  organization: Mali Office, Helen Keller International, Bamako, Mali
– sequence: 4
  givenname: Steven D
  surname: Reid
  fullname: Reid, Steven D
  organization: Headquarters, Helen Keller International, New York, New York, United States of America
– sequence: 5
  givenname: Mahamadou
  surname: Dembéle
  fullname: Dembéle, Mahamadou
  organization: Programme National de la Santé Oculaire, Ministère de la Santé, Bamako, Mali
– sequence: 6
  givenname: Bréhima
  surname: Mariko
  fullname: Mariko, Bréhima
  organization: District Sanitaire de Kita, Direction Régionale de la Santé de Kayes, Kita, Mali
– sequence: 7
  givenname: Famolo
  surname: Coulibaly
  fullname: Coulibaly, Famolo
  organization: Programme National de la Santé Oculaire, Ministère de la Santé, Bamako, Mali
– sequence: 8
  givenname: Whitney
  orcidid: 0000-0003-4935-6545
  surname: Goldman
  fullname: Goldman, Whitney
  organization: Headquarters, Helen Keller International, New York, New York, United States of America
– sequence: 9
  givenname: Dramane
  surname: Traoré
  fullname: Traoré, Dramane
  organization: Mali Office, Helen Keller International, Bamako, Mali
– sequence: 10
  givenname: Daouda
  surname: Coulibaly
  fullname: Coulibaly, Daouda
  organization: Programme National de la Santé Oculaire, Ministère de la Santé, Bamako, Mali
– sequence: 11
  givenname: Boubacar
  surname: Guindo
  fullname: Guindo, Boubacar
  organization: Mali Office, Helen Keller International, Bamako, Mali
– sequence: 12
  givenname: Joseph J
  orcidid: 0000-0002-2455-6703
  surname: Amon
  fullname: Amon, Joseph J
  organization: Headquarters, Helen Keller International, New York, New York, United States of America
– sequence: 13
  givenname: Marily
  surname: Knieriemen
  fullname: Knieriemen, Marily
  organization: Mali Office, Helen Keller International, Bamako, Mali
– sequence: 14
  givenname: Yaobi
  orcidid: 0000-0002-7370-9171
  surname: Zhang
  fullname: Zhang, Yaobi
  organization: Regional Office for Africa, Helen Keller International, Dakar, Senegal
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29432434$$D View this record in MEDLINE/PubMed
BookMark eNptUl1v0zAUjdAQ2wr_AIElJMRLi7_ixC-TpomPiSF4gGfLca5TV4ld7GRS_z0O7aYWTX6wde85x_fjXBZnPngoitcErwiryMdNmKLX_Wrrx3aFMRa0ls-KCyJZuaQVK8-O3ufFZUobjEtZ1uRFcU4lZ5QzflHYnxHudQ_eAAoWjVGbdRg0ch6Na0Df9A4SitC54Of8d907BK5bj2gHOiak7QgRpTFst853aNApoTZOHdLt4LxLWXDM3JfFc6v7BK8O96L4_fnTr5uvy7sfX25vru-WRlA-Lmst2pLWrKaScKFzn6ZqLIVGMIOrRpiSNxxK01Z1C6YGIxpqK66xpJVgrGaL4u1ed9uHpA4jSopiwrkUtagy4naPaIPeqG10g447FbRT_wIhdkrH0ZkeFGAurOSkAttwbKTWklsm8zxZRVljs9bV4bepGaA14HO7_Ynoaca7terCvSprWpJc8KL4cBCI4c8EaVSDSwb6XnsI01w3JpIISebO3v0Hfbq7A6rLO1XO2zBvdBZV12XeOi1xKTJq9QQqnxYGZ7LNrMvxE8L7I8IadD-uU-inebXpFMj3QBNDShHs4zAIVrNtH6pWs23VwbaZ9uZ4kI-kB5-yv4916yA
CitedBy_id crossref_primary_10_1186_s13052_022_01258_x
crossref_primary_10_1097_CM9_0000000000001717
Cites_doi 10.1016/j.inhe.2009.08.001
10.4269/ajtmh.2003.69.5_suppl_1.0690033
10.4269/ajtmh.2003.69.18
10.1093/ije/25.1.198
10.1371/journal.pntd.0000835
10.1111/j.1365-3156.2009.02459.x
10.1016/S0140-6736(95)90167-1
10.1046/j.1365-3156.2000.00603.x
10.2471/BLT.07.046326
10.1016/S0140-6736(98)09158-2
10.1016/S0140-6736(97)01355-X
10.4269/ajtmh.2011.10-0720
10.1080/09286580802080090
10.1016/S2214-109X(13)70113-X
10.1076/opep.8.2.145.4169
10.1136/bjo.2004.041657
10.1016/j.inhe.2011.03.004
10.1371/journal.pmed.1001605
10.1371/journal.pntd.0000734
ContentType Journal Article
Copyright COPYRIGHT 2018 Public Library of Science
2018 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Traoré L, Dembele B, Keita M, Reid SD, Dembéle M, Mariko B, et al. (2018) Prevalence of trachoma in the Kayes region of Mali eight years after stopping mass drug administration. PLoS Negl Trop Dis 12(2): e0006289. https://doi.org/10.1371/journal.pntd.0006289
2018 Traoré et al 2018 Traoré et al
2018 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Traoré L, Dembele B, Keita M, Reid SD, Dembéle M, Mariko B, et al. (2018) Prevalence of trachoma in the Kayes region of Mali eight years after stopping mass drug administration. PLoS Negl Trop Dis 12(2): e0006289. https://doi.org/10.1371/journal.pntd.0006289
Copyright_xml – notice: COPYRIGHT 2018 Public Library of Science
– notice: 2018 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Traoré L, Dembele B, Keita M, Reid SD, Dembéle M, Mariko B, et al. (2018) Prevalence of trachoma in the Kayes region of Mali eight years after stopping mass drug administration. PLoS Negl Trop Dis 12(2): e0006289. https://doi.org/10.1371/journal.pntd.0006289
– notice: 2018 Traoré et al 2018 Traoré et al
– notice: 2018 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Traoré L, Dembele B, Keita M, Reid SD, Dembéle M, Mariko B, et al. (2018) Prevalence of trachoma in the Kayes region of Mali eight years after stopping mass drug administration. PLoS Negl Trop Dis 12(2): e0006289. https://doi.org/10.1371/journal.pntd.0006289
DBID NPM
AAYXX
CITATION
3V.
7QL
7SS
7T2
7T7
7U9
7X7
7XB
88E
8C1
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
C1K
CCPQU
DWQXO
F1W
FR3
FYUFA
GHDGH
H94
H95
H97
K9.
L.G
M0S
M1P
M7N
P64
PIMPY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.1371/journal.pntd.0006289
DatabaseName PubMed
CrossRef
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Entomology Abstracts (Full archive)
Health and Safety Science Abstracts (Full archive)
Industrial and Applied Microbiology Abstracts (Microbiology A)
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Public Health Database (Proquest)
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central
ASFA: Aquatic Sciences and Fisheries Abstracts
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources
Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality
ProQuest Health & Medical Complete (Alumni)
Aquatic Science & Fisheries Abstracts (ASFA) Professional
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
Aquatic Science & Fisheries Abstracts (ASFA) Professional
Technology Research Database
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality
Environmental Sciences and Pollution Management
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Health & Safety Science Abstracts
Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Medical Library (Alumni)
ProQuest Public Health
Virology and AIDS Abstracts
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Entomology Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ASFA: Aquatic Sciences and Fisheries Abstracts
Engineering Research Database
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

Publicly Available Content Database


PubMed


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Prevalence of trachoma in Mali
EISSN 1935-2735
Editor Schachter, Julius
Editor_xml – sequence: 1
  givenname: Julius
  surname: Schachter
  fullname: Schachter, Julius
EndPage e0006289
ExternalDocumentID 2014496867
oai_doaj_org_article_e046f9417efb40c9aa94f397353723bf
A529425056
10_1371_journal_pntd_0006289
29432434
Genre Journal Article
GeographicLocations Mali
GeographicLocations_xml – name: Mali
GrantInformation_xml – fundername: ;
  grantid: 20130058
GroupedDBID ---
123
29O
2WC
3V.
53G
5VS
7X7
88E
8C1
8FI
8FJ
AAFWJ
ABDBF
ABUWG
ACGFO
ACIHN
ACPRK
ADBBV
ADRAZ
AEAQA
AENEX
AFKRA
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
BWKFM
CCPQU
CS3
DIK
DU5
E3Z
EAP
EAS
EBD
ECGQY
EMOBN
ESX
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
IAO
IHR
IHW
IPNFZ
ITC
KQ8
M1P
M48
M~E
NPM
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
PV9
RIG
RNS
RPM
RZL
SV3
TR2
TUS
UKHRP
WOQ
AAYXX
CITATION
AFPKN
7QL
7SS
7T2
7T7
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
F1W
FR3
H94
H95
H97
K9.
L.G
M7N
P64
PQEST
PQUKI
7X8
5PM
-
AAPBV
ABPTK
ADACO
BBAFP
PRINS
ID FETCH-LOGICAL-c624t-8a6d5283829146a137c7bf2eb63c07b6c54b4e5cd78dec8ec6b2f74a092763383
IEDL.DBID RPM
ISSN 1935-2735
1935-2727
IngestDate Sun May 01 00:10:40 EDT 2022
Tue Oct 22 15:09:35 EDT 2024
Tue Sep 17 21:22:03 EDT 2024
Fri Oct 25 09:06:03 EDT 2024
Sun Nov 24 01:18:49 EST 2024
Tue Nov 19 21:09:28 EST 2024
Tue Nov 12 23:16:54 EST 2024
Tue Aug 20 22:08:42 EDT 2024
Thu Nov 21 22:46:39 EST 2024
Wed Oct 16 00:59:06 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
License This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c624t-8a6d5283829146a137c7bf2eb63c07b6c54b4e5cd78dec8ec6b2f74a092763383
Notes new_version
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
The authors have declared that no competing interests exist.
ORCID 0000-0003-4935-6545
0000-0002-2455-6703
0000-0002-7370-9171
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825163/
PMID 29432434
PQID 2014496867
PQPubID 1436337
ParticipantIDs plos_journals_2014496867
doaj_primary_oai_doaj_org_article_e046f9417efb40c9aa94f397353723bf
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5825163
proquest_miscellaneous_2001916918
proquest_journals_2014496867
gale_infotracmisc_A529425056
gale_infotracacademiconefile_A529425056
gale_healthsolutions_A529425056
crossref_primary_10_1371_journal_pntd_0006289
pubmed_primary_29432434
PublicationCentury 2000
PublicationDate 2018-02-12
PublicationDateYYYYMMDD 2018-02-12
PublicationDate_xml – month: 02
  year: 2018
  text: 2018-02-12
  day: 12
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, CA USA
PublicationTitle PLoS neglected tropical diseases
PublicationTitleAlternate PLoS Negl Trop Dis
PublicationYear 2018
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References 28664685 - Wkly Epidemiol Rec. ;92 (26):359-68
10995092 - Trop Med Int Health. 2000 Aug;5(8):515-27
18780261 - Ophthalmic Epidemiol. 2008 Jul-Aug;15(4):272-8
10191556 - Bull World Health Organ. 1998;76(6):599-606
24036560 - Int Health. 2009 Dec;1(2):154-62
24586120 - PLoS Med. 2014 Feb 25;11(2):e1001605
8666490 - Int J Epidemiol. 1996 Feb;25(1):198-203
20957147 - PLoS Negl Trop Dis. 2010 Oct 05;4(10):null
19274367 - Bull World Health Organ. 2009 Feb;87(2):143-51
25275153 - Wkly Epidemiol Rec. 2014 Sep 26;89(39):421-8
20625555 - PLoS Negl Trop Dis. 2010 Jul 06;4(7):e734
9167460 - Lancet. 1997 May 24;349(9064):1511-2
21896815 - Am J Trop Med Hyg. 2011 Sep;85(3):518-23
10227221 - Lancet. 1999 Apr 24;353(9162):1401-3
15489474 - Br J Ophthalmol. 2004 Nov;88(11):1368-71
3500800 - Bull World Health Organ. 1987;65(4):477-83
20070630 - Trop Med Int Health. 2010 Mar;15(3):306-11
11471084 - Ophthalmic Epidemiol. 2001 Jul;8(2-3):145-53
21785663 - Int Health. 2011 Jun;3(2):75-84
14692679 - Am J Trop Med Hyg. 2003 Nov;69(5 Suppl):33-5
14692676 - Am J Trop Med Hyg. 2003 Nov;69(5 Suppl):18-23
25104599 - Lancet Glob Health. 2013 Dec;1(6):e339-49
7823670 - Lancet. 1995 Jan 21;345(8943):155-8
ref13
ref12
S West (ref35) 1995; 345
ref32
ref2
ref17
PJ Dolin (ref26) 1997; 349
ME Stocks (ref30) 2014; 11
(ref3) 2017; 92
ref16
ref18
S Bamani (ref15) 2010; 4
PM Emerson (ref4) 2000; 5
LA Rotondo (ref31) 2009; 1
AA Cruz (ref36) 2008; 15
SK West (ref1) 2003; 69
NE Stoller (ref34) 2011; 3
RR Bourne (ref5) 2013; 1
JF Schemann (ref7) 1998; 76
PM Emerson (ref11) 1999; 353
ref24
S West (ref21) 2004; 88
SP Mariotti (ref10) 2001
J Ngondi (ref19) 2009; 87
G Kalton (ref20) 1983; 51
S Bamani (ref25) 2010; 15
(ref14) 2006
(ref29) 2014; 89
ref8
SP Mariotti (ref9) 2003; 69
ref6
MJ Burton (ref28) 2010; 4
T Gebre (ref33) 2011; 85
A Hoechsmann (ref27) 2001; 8
B Thylefors (ref23) 1987; 65
AG Turner (ref22) 1996; 25
References_xml – volume: 1
  start-page: 154
  issue: 2
  year: 2009
  ident: ref31
  article-title: Evaluation of community intervention with pit latrines for trachoma control in Ghana, Mali, Niger and Nigeria
  publication-title: Int Health
  doi: 10.1016/j.inhe.2009.08.001
  contributor:
    fullname: LA Rotondo
– volume: 69
  start-page: 33
  issue: 5 Suppl
  year: 2003
  ident: ref9
  article-title: Trachoma: looking forward to Global Elimination of Trachoma by 2020 (GET 2020)
  publication-title: Am J Trop Med Hyg
  doi: 10.4269/ajtmh.2003.69.5_suppl_1.0690033
  contributor:
    fullname: SP Mariotti
– volume: 76
  start-page: 599
  issue: 6
  year: 1998
  ident: ref7
  article-title: Cartography of trachoma in Mali: results of a national survey
  publication-title: Bull World Health Organ
  contributor:
    fullname: JF Schemann
– ident: ref24
– volume: 69
  start-page: 18
  issue: 5 Suppl
  year: 2003
  ident: ref1
  article-title: Blinding trachoma: prevention with the safe strategy
  publication-title: Am J Trop Med Hyg
  doi: 10.4269/ajtmh.2003.69.18
  contributor:
    fullname: SK West
– year: 2006
  ident: ref14
  article-title: Trachoma Control: a guide for program managers
– volume: 25
  start-page: 198
  issue: 1
  year: 1996
  ident: ref22
  article-title: A not quite as quick but much cleaner alternative to the Expanded Programme on Immunization (EPI) Cluster Survey design
  publication-title: Int J Epidemiol
  doi: 10.1093/ije/25.1.198
  contributor:
    fullname: AG Turner
– volume: 65
  start-page: 477
  issue: 4
  year: 1987
  ident: ref23
  article-title: A simple system for the assessment of trachoma and its complications
  publication-title: Bull World Health Organ
  contributor:
    fullname: B Thylefors
– ident: ref32
– volume: 4
  issue: 10
  year: 2010
  ident: ref28
  article-title: Profound and sustained reduction in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic communities
  publication-title: PLoS Negl Trop Dis
  doi: 10.1371/journal.pntd.0000835
  contributor:
    fullname: MJ Burton
– volume: 89
  start-page: 421
  issue: 39
  year: 2014
  ident: ref29
  article-title: WHO alliance for the global elimination of blinding trachoma by the year 2020: progress report on elimination of trachoma, 2013
  publication-title: Weekly Epidemiological Record
– ident: ref17
– volume: 15
  start-page: 306
  issue: 3
  year: 2010
  ident: ref25
  article-title: Evaluation of the prevalence of trachoma 12 years after baseline surveys in Kidal Region, Mali
  publication-title: Trop Med Int Health
  doi: 10.1111/j.1365-3156.2009.02459.x
  contributor:
    fullname: S Bamani
– volume: 345
  start-page: 155
  issue: 8943
  year: 1995
  ident: ref35
  article-title: Impact of face-washing on trachoma in Kongwa, Tanzania
  publication-title: Lancet
  doi: 10.1016/S0140-6736(95)90167-1
  contributor:
    fullname: S West
– ident: ref13
– ident: ref2
– volume: 5
  start-page: 515
  issue: 8
  year: 2000
  ident: ref4
  article-title: Review of the evidence base for the ‘F’ and ‘E’ components of the SAFE strategy for trachoma control
  publication-title: Trop Med Int Health
  doi: 10.1046/j.1365-3156.2000.00603.x
  contributor:
    fullname: PM Emerson
– volume: 87
  start-page: 143
  issue: 2
  year: 2009
  ident: ref19
  article-title: Trachoma survey methods: a literature review
  publication-title: Bull World Health Organ
  doi: 10.2471/BLT.07.046326
  contributor:
    fullname: J Ngondi
– ident: ref6
– volume: 353
  start-page: 1401
  issue: 9162
  year: 1999
  ident: ref11
  article-title: Effect of fly control on trachoma and diarrhoea
  publication-title: Lancet
  doi: 10.1016/S0140-6736(98)09158-2
  contributor:
    fullname: PM Emerson
– volume: 349
  start-page: 1511
  issue: 9064
  year: 1997
  ident: ref26
  article-title: Reduction of trachoma in a sub-Saharan village in absence of a disease control programme
  publication-title: Lancet
  doi: 10.1016/S0140-6736(97)01355-X
  contributor:
    fullname: PJ Dolin
– volume: 85
  start-page: 518
  issue: 3
  year: 2011
  ident: ref33
  article-title: Latrine promotion for trachoma: assessment of mortality from a cluster-randomized trial in Ethiopia
  publication-title: Am J Trop Med Hyg
  doi: 10.4269/ajtmh.2011.10-0720
  contributor:
    fullname: T Gebre
– volume: 15
  start-page: 272
  issue: 4
  year: 2008
  ident: ref36
  article-title: Prevalence of trachoma in a population of the upper Rio Negro basin and risk factors for active disease
  publication-title: Ophthalmic Epidemiol
  doi: 10.1080/09286580802080090
  contributor:
    fullname: AA Cruz
– volume: 1
  start-page: e339
  issue: 6
  year: 2013
  ident: ref5
  article-title: Causes of vision loss worldwide, 1990–2010: a systematic analysis
  publication-title: Lancet Glob Health
  doi: 10.1016/S2214-109X(13)70113-X
  contributor:
    fullname: RR Bourne
– volume: 8
  start-page: 145
  issue: 2–3
  year: 2001
  ident: ref27
  article-title: Reduction of trachoma in the absence of antibiotic treatment: evidence from a population-based survey in Malawi
  publication-title: Ophthalmic Epidemiol
  doi: 10.1076/opep.8.2.145.4169
  contributor:
    fullname: A Hoechsmann
– volume: 88
  start-page: 1368
  issue: 11
  year: 2004
  ident: ref21
  article-title: Gender equity and trichiasis surgery in the Vietnam and Tanzania national trachoma control programmes
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.2004.041657
  contributor:
    fullname: S West
– volume: 51
  start-page: 175
  issue: 2
  year: 1983
  ident: ref20
  article-title: Models in the Practice of Survey Sampling
  publication-title: International Statistical Review / Revue Internationale de Statistique
  contributor:
    fullname: G Kalton
– volume: 92
  start-page: 357
  issue: 26
  year: 2017
  ident: ref3
  article-title: WHO Alliance for the Global Elimination of Trachoma by 2020: progress report on elimination of trachoma, 2014–2016
  publication-title: Weekly epidemiological record
– ident: ref8
– ident: ref18
– year: 2001
  ident: ref10
  article-title: The SAFE strategy: Preventing trachoma—a guide for environmental sanitation and improved hygiene
  contributor:
    fullname: SP Mariotti
– ident: ref16
– volume: 3
  start-page: 75
  issue: 2
  year: 2011
  ident: ref34
  article-title: Efficacy of latrine promotion on emergence of infection with ocular Chlamydia trachomatis after mass antibiotic treatment: a cluster-randomized trial
  publication-title: Int Health
  doi: 10.1016/j.inhe.2011.03.004
  contributor:
    fullname: NE Stoller
– volume: 11
  start-page: e1001605
  issue: 2
  year: 2014
  ident: ref30
  article-title: Effect of water, sanitation, and hygiene on the prevention of trachoma: a systematic review and meta-analysis
  publication-title: PLoS Med
  doi: 10.1371/journal.pmed.1001605
  contributor:
    fullname: ME Stocks
– ident: ref12
– volume: 4
  start-page: e734
  issue: 7
  year: 2010
  ident: ref15
  article-title: Where do we go from here? Prevalence of trachoma three years after stopping mass distribution of antibiotics in the regions of Kayes and Koulikoro, Mali
  publication-title: PLoS Negl Trop Dis
  doi: 10.1371/journal.pntd.0000734
  contributor:
    fullname: S Bamani
SSID ssj0059581
Score 2.2705867
Snippet In 2009, three years after stopping mass treatment with azithromycin, a trachoma impact survey in four health districts in the Kayes region of Mali found a...
Background In 2009, three years after stopping mass treatment with azithromycin, a trachoma impact survey in four health districts in the Kayes region of Mali...
BACKGROUNDIn 2009, three years after stopping mass treatment with azithromycin, a trachoma impact survey in four health districts in the Kayes region of Mali...
Trachoma is a leading infectious cause of preventable blindness worldwide. The World Health Organization (WHO) recommends that endemic states implement the...
Background In 2009, three years after stopping mass treatment with azithromycin, a trachoma impact survey in four health districts in the Kayes region of Mali...
SourceID plos
doaj
pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage e0006289
SubjectTerms Antibiotics
Azithromycin
Biology and Life Sciences
Causes of
Children
Chlamydia
Chlamydia trachomatis
Confidence intervals
Demographic aspects
Diagnosis
Evaluation
Households
International
Medicine and Health Sciences
Methods
People and Places
Prevalence studies (Epidemiology)
Random sampling
Statistical sampling
Surgery
Surveying
Surveys
Systematic review
Trachoma
Tropical diseases
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELbQHhAXxLspCxgJiZNp1vHzWBBVBSonKvUW2Y4NlSBZdXcP_ffM2Nlogypx4ZqxHHle_px4viHknVMppeAE0zZ4JkIyzMAuwYQ2Xao7HVW5IPtNnV-KL1fy6qDVF94JK_TARXEnEQ5wyYqVjsmLOljnrEiwiTay0bzxKWffmu8PUyUHSytze1JAJ1hxxfVYNNfo1cloow_rftshe6Hi2OL9YFPK3P1Thl6sfw2bu-Dn37coD7als0fk4Ygn6WlZx2NyL_ZPyP2L8Y_5U5KQo8nlyiI6JApTYHcUR697CtCPfnW3cUOxO8PQo_wCYDnNX0vpLcTAhuYe4hTpB7Cwiv4GrE27m90P6masu8_I5dnn75_O2dhbgQXFxZYZpzrkdTHcQq50oJmgfeLRqybU2qsghRdRhg5sFoOJQXmetHC15ZCR4Fj7nCz6oY9HhCaAYEomJ6UWwvKVj6kTMGOMQXhndEXYXrntulBotPk_moajR9FSi8ZoR2NU5CNaYBqLBNj5AbhFO7pF-y-3qMgbtF9bqkmnMG5PJbciw76KvM8jMJBR-W6sR4BFISXWbORyNhICMMzER-gj-7VsWo6nVKuMgqUv935zt_jtJMZJ8b5bH4cdjgHojTxGpiIviptN-oD3AgpuREX0zAFnCptL-uufmTlcYqGyao7_h4ZfkgewEsNyc5wlWWxvdvEVALStf51j8Q8p0jfy
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLagkxAviPsCA4yExJOhdXzLE9rQpgm0CSEm7S2yHXubBElp2of9e85x3LCgicfWrpucmz9fzncIeWdVjNFbwXTlHRM-GmZglmBCmybOGx3UcEH2VB2fiS_n8jxvuPX5WuU2JqZA3XQe98hhkQ7Qv1JG6U_L3wyrRuHpai6hcZfs8EVpzIzsHByefvu-jcWykqlMKaAUzLziOifPlXrxMevqw7JdN8hiqDiWer8xOSUO_zFSz5Y_u_42GPrvbcob09PRQ_Ig40q6PxjCI3IntI_JvZN8cv6ERORqsinDiHaRwhBYJcXSq5YCBKRf7XXoKVZp6FpsPwF4TtOuKb0GX-hpqiVOkYYAE6zoL8DctFltLqidsO8-JWdHhz8-H7NcY4F5xcWaGasa5HcxvIKYaUEyXrvIg1Oln2unvBROBOkb0F3wJnjleNTCzisOkQmWt8_IrO3asEtoBCimZLRSatAUX7gQGwEjhuCFs0YXhG2FWy8HKo06nadpWIIMUqpRGXVWRkEOUANjXyTCTl90q4s6-1UdYH0fK7HQITox95W1lYiAsUpZal66WJA3qL96yCod3bnel7wSCf4V5H3qgQ6Nwrc5LwFeCqmxJj33Jj3BEf2keRdtZPsuff3XZOGXW7u5vfnt2IyD4r23NnQb7AMQHPmMTEGeD2Y2ygP-F9BwKQqiJwY4Edi0pb26TAziEhOWVfni_4_1ktyHD4al8jd7ZLZebcIrgGBr9zr72R8p-jEa
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdGkRAvE98LFDASEk-ZWsefDwgNxDSByhOV9hbZjj0mjaQ0rbT-99w5aURQ4bXnOPX5zv5d7PsdIW-tjDF6y3NlvMu5jzrXsEvkXOkqzioVZHdB9pu8WPIvl-LyiOxrtvYKbA-GdlhParm-Ob39tfsADv8-VW1Q8_1Dp6t6UyEfoYQg4g65y2BvxEteCz6cKwgjUtlSQC2YicVUn0z3r15Gm1Xi9B9W7snqpmkPwdK_b1f-sV2dPyDHPc6kZ51hPCRHoX5E7i36k_THJCJ3k00ZR7SJFLrAqimWXtcUICH9anehpVi1oalRvgC4TtNXVLoD32hpqi1OkZYAE67oT8DgtFpvr6gdsfE-Icvzz98_XeR9zYXcS8Y3ubayQr4XzQysoRY045WLLDhZ-Jly0gvueBC-grkMXgcvHYuK25lhsFJBuPuUTOqmDieERoBmUkQrhOLcsLkLseLQYwieO6tVRvK9cstVR61RpvM1BSFJp6USJ6PsJyMjH3EGhrZIjJ1-aNZXZe9nZYB4Pxo-VyE6PvPGWsMjYK5CFIoVLmbkNc5f2WWZDu5dnglmeIKDGXmXWqDJofJtn6cAg0KqrFHL6aglOKYfiU_QRvZjaUuG0auRWsLQp3u7OSx-M4ixU7wHV4dmi20AkiO_kc7Is87MBn3AewEdFzwjamSAI4WNJfX1j8QoLjCBWRbP_z-gF-Q-_Eedp3I4UzLZrLfhJUCyjXuVvOw3SgY1Og
  priority: 102
  providerName: Scholars Portal
Title Prevalence of trachoma in the Kayes region of Mali eight years after stopping mass drug administration
URI https://www.ncbi.nlm.nih.gov/pubmed/29432434
https://www.proquest.com/docview/2014496867
https://search.proquest.com/docview/2001916918
https://pubmed.ncbi.nlm.nih.gov/PMC5825163
https://doaj.org/article/e046f9417efb40c9aa94f397353723bf
http://dx.doi.org/10.1371/journal.pntd.0006289
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBbJFkovpe-42W5VKPTkfdh6-ZgsCaFlQygN7M1IspQsZO1lH4f8-8zID-qSUy8-rLTGmof0jT3zDSHftfDeW81imVkTM-tVrOCUiJlUhZ8W0ok6QfZaXN2yn0u-PCK8rYUJSfvWrMblw3pcru5DbuVmbSdtntjkZjHnWG8p0skxOYbjtw3R6-2XZzx0JgVggsVWiWzq5VI5mzTqGW_KfYHEhQKiDWQDzpCWLmW9oykw-Hf79GDzUO2eA6H_5lL-dThdviGvG1RJz-qnf0uOXPmOvFw0383fE49MTTrUF9HKU7gF9kjRdFVSAID0l350O4o9GqoSxxcAzml4Z0ofwRN2NHQSp0hCgOVVdA2Imxbbwx3VPe7dD-T28uLP_CpuOizEViRsHystCmR3UUkGO6YGIVlpfOKMSO1UGmE5M8xxW4DmnFXOCpN4yfQ0S2BfguD2IxmUVelOCPUAxAT3mnPJWJbMjPMFgzs6Z5nRSkYkboWbb2oijTx8TZMQgNRSylEveaOXiJyjBrq5SIMdfqi2d3ljDLmD6N5nbCadN2xqM60z5gFhpTyVSWp8RL6i_vK6prRz5vyMg84D-IvIjzAD3RmFr5uqBFgUEmP1Zg57M8ENbW_4BG2kXcsuTzBWzYQSsPRhazfPD3_rhvGmmPVWuuqAcwCAI5uRisin2sw6ebRGGxHZM8CewPoj4E6BP7xxn8___c9T8goeX8WhL86QDPbbg_sC2GxvRuCRSwlXNZ-NyIvzi-ub36PwngOuC6ZGwVefAA6_Pbg
link.rule.ids 230,314,727,780,784,864,885,2102,2221,12056,12223,21388,24318,27924,27925,31719,31720,33266,33267,33744,33745,43310,43579,43805,53791,53793,73745,74014,74302
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZgkaAXxLuBQo2ExCmwm_iVEyoV1UK7PbVSb5bt2KUSJNvN7qH_nhnHGxpUcd1xnM087M-P-YaQD0aEEJxhuayczZkLKlcwS-RMqjpMa-lFf0H2VMzP2Y8LfpE23Lp0rXI7JsaBum4d7pHDIh2gfyWUkF-W1zlWjcLT1VRC4z55ANO-RK9Wh8MVD17xWKQUMArmXRUypc6VcvY5WerTslnXyGEoCiz0fmtqigz-wzg9Wf5qu7tA6L93KW9NTkdPyOOEKulB7wZPyT3fPCMPF-nc_DkJyNRkYn4RbQOFLrBGiqFXDQUASI_Nje8o1mhoG5QvAJzTuGdKbyASOhoriVMkIcD0KvobEDetV5tLakbcuy_I-dG3s8N5nios5E4UbJ0rI2pkd1FFBSOmAc04aUPhrSjdVFrhOLPMc1eD5bxT3glbBMnMtCpgXILF7UsyadrG7xIaAIgJHgznEuxUzKwPNYMevXfMGiUzkm-Vq5c9kYaOp2kSFiC9ljQaQydjZOQrWmBoizTY8Yd2dalTVGkPq_tQsZn0wbKpq4ypWACEVfJSFqUNGdlH--k-p3QIZn3Ai4pF8JeRj7EFhjMq36SsBPgoJMYatdwbtYQwdCPxLvrI9ls6_ddh4cmt39wtfj-IsVO89db4doNtAIAjm5HKyKvezQZ9wHsBC5csI3LkgCOFjSXN1c_IH84xXVmUr___t_bJo_nZ4kSffD89fkN2QKDyWAhnj0zWq41_C2Bsbd_FiPsDNR4ycA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZgkSouiHfTFmokJE6mu4lfOaFSWBVKKw5U6i2yHbutBMmy2T303zPjeEODKq6x4yTzsD_HM98Q8tbIEIIznKnSWcZd0EzDKsG40nWY1srLPkD2TB6f868X4iLFP3UprHIzJ8aJum4d_iOHTTpA_1JqqQ5CCov4_mn-YfGbYQUpPGlN5TTukwdYZQ559PXREO4hShELlgJewRysXKU0ukLNDpLW3i-aVY18hjLHou-3lqnI5j_M2ZPFz7a7C5D-G1d5a6GaPyaPEsKkh71JPCH3fPOUbJ2mM_RnJCBrk4m5RrQNFIbAeimGXjcUwCA9MTe-o1ivoW2w_RSAOo3_T-kNeEVHY1VxioQEmGpFfwH6pvVyfUnNiIf3OTmff_5xdMxStQXmZM5XTBtZI9OLzkuYPQ1Ixikbcm9l4abKSie45V64GrTonfZO2jwobqZlDnMUbHRfkEnTNn6b0ACgTIpghFCgs3xmfag5jOi949ZolRG2EW616Ek1qniypmAz0kupQmVUSRkZ-YgaGPoiJXa80C4vq-RhlYedfij5TPlg-dSVxpQ8ANoqRKHywoaM7KP-qj6_dHDs6lDkJY9AMCPvYg90bRS-SRkK8FFIkjXquTfqCS7pRs3baCObb-mqv8YLd27s5u7mN0MzDooRcI1v19gHwDgyG-mMvOzNbJAHPBdwccEzokYGOBLYuKW5vopc4gJTl2Wx8__X2idb4GzVty9nJ7vkIVzXLNbE2SOT1XLtXwEuW9nX0eH-AIKvNpU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+of+trachoma+in+the+Kayes+region+of+Mali+eight+years+after+stopping+mass+drug+administration&rft.jtitle=PLoS+neglected+tropical+diseases&rft.au=Traor%C3%A9%2C+Lamine&rft.au=Dembele%2C+Benoit&rft.au=Keita%2C+Modibo&rft.au=Reid%2C+Steven+D&rft.date=2018-02-12&rft.pub=Public+Library+of+Science&rft.issn=1935-2727&rft.volume=12&rft.issue=2&rft_id=info:doi/10.1371%2Fjournal.pntd.0006289&rft.externalDocID=A529425056
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1935-2735&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1935-2735&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1935-2735&client=summon